Advanced search
Publication Cover
Acta Cardiologica Volume 76, 2021 - Issue 1
Submit an article Journal homepage
143
Views
3
CrossRef citations to date
0
Altmetric
Original Scientific Paper

Feasibility of right coronary artery first ergonovine provocation test

Hyun Seok Hama Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea
,
Ki-Hun Kimb Department of Internal Medicine, Division of Cardiology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, KoreaCorrespondence[email protected]
,
Jino Parkb Department of Internal Medicine, Division of Cardiology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea
,
Yeo-Jeong Songb Department of Internal Medicine, Division of Cardiology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea
,
Seunghwan Kimb Department of Internal Medicine, Division of Cardiology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea
,
Dong-Kie Kimb Department of Internal Medicine, Division of Cardiology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea
,
Sang-Hoon Seolb Department of Internal Medicine, Division of Cardiology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea
&
Doo-Il Kimb Department of Internal Medicine, Division of Cardiology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea
 show all
Pages 38-45 | Received 11 Oct 2019, Accepted 29 Oct 2019, Published online: 09 Nov 2019

References

  • Ciliberti G, Seshasai SRK, Ambrosio G, et al. Safety of intracoronary provocative testing for the diagnosis of coronary artery spasm. Int J Cardiol. 2017;244:77–83.
  • Sueda S, Kohno H. Overview of complications during pharmacological spasm provocation tests. J Cardiol. 2016;68:1–6.
  • Ahn JM, Lee KH, Yoo SY, et al. Prognosis of variant angina manifesting as aborted sudden cardiac death. J Am Coll Cardiol. 2016;68:137–145.
  • Slavich M, Patel RS. Coronary artery spasm: current knowledge and residual uncertainties. Int J Cardiol Heart Vasc. 2016;10:47–53.
  • Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2019;0:1–71.
  • JCS Joint Working Group. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2013). Circ J. 2014;78:2779–2801.
  • Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;64:e139–e228.
  • Sueda S, Miyoshi T, Sasaki Y, et al. Safety and optimal protocol of provocation test for diagnosis of multivessel coronary spasm. Heart Vessels. 2016;31:137–142.
  • Shin DI, Baek SH, Her SH, et al. The 24-month prognosis of patients with positive or intermediate results in the intracoronary ergonovine provocation test. JACC Cardiovasc Interv. 2015;8:914–923.
  • Isogai T, Yasunaga H, Matsui H, et al. Serious cardiac complications in coronary spasm provocation tests using acetylcholine or ergonovine: analysis of 21 512 patients from the diagnosis procedure combination database in japan. Clin Cardiol. . 2015;38:171–177.
  • Kim YG, Kim HJ, Choi WS, et al. Does a negative ergonovine provocation test truly predict freedom from variant angina? Korean Circ J. 2013;43:199–203.
  • Zaya M, Mehta PK, Merz CN. Provocative testing for coronary reactivity and spasm. J Am Coll Cardiol. 2014;63:103–109.
  • Kim JH, Kim C, Kim J, et al. The effect of intracoronary administration of ergonovine on the contralateral coronary artery in a provocation test for the diagnosis of variant angina. Acta Cardiol. 2014;69:628–634.
  • Takagi Y, Yasuda S, Takahashi J, et al. Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: Multicentre registry study of the Japanese coronary spasm association. Eur Heart J. 2013;34:258–267.
  • Song JK, Park SW, Kang DH, et al. Safety and clinical impact of ergonovine stress echocardiography for diagnosis of coronary vasospasm. J Am Coll Cardiol. 2000;35:1850–1856.
  • Suzuki Y, Tokunaga S, Ikeguchi S, et al. Induction of coronary artery spasm by intracoronary acetylcholine: comparison with intracoronary ergonovine. Am Heart J. 1992;124:39–47.
  • Al Mheid I, Hayek S, Quyyumi AA. Provoking coronary vasospasm for diagnosis of variant angina: outdated trick of the trade or a resurgent diagnostic modality? JACC Cardiovasc Interv. 2015;8:924–926.
  • Kobayashi T, Hirshfeld JW Jr. Radiation exposure in cardiac catheterization: operator behavior matters. Circ Cardiovasc Interv. 2017;10;e005689.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.